Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can storytelling and support groups break the stigma around cancer in rwanda?

NCT ID NCT07663006

Knowledge-focused Sponsor: Dana-Farber Cancer Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how common stigma is for breast and cervical cancer patients, caregivers, and community health workers in Rwanda. It also tests a program called RISE that includes resilience training, support groups, and videos of cancer survivors to see if it can reduce stigma. The goal is to find ways to make people feel more comfortable talking about cancer and seeking help.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
RISE Intervention (resilience training, support groups, survivor videos) and CHW Educational Intervention (survivor videos, educational materials)
What this could lead to
If successful, this could provide a proven way to reduce cancer stigma in Rwanda, improving support for patients and encouraging earlier diagnosis.
What could go wrong
This is a pilot study, so the intervention may not reduce stigma as hoped. Results may also not apply to other regions or cultures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,116 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Aim 1 Inclusion and Exclusion Criteria Aim 1 Interviews and Surveys Individual interviews and surveys: Potential patients will be identified by the clinical team from physical and electronic registries of patients. Potential participants will be screened for eligibility by the study research assistant. Inclusion Criteria * Patients with pathologically confirmed breast or cervical cancer * Patients receiving treatment at BCCOE during the study period * Age 18 and over * Ability to provide informed consent * Ability to participate in interview or surveys in English or Kinyarwanda Exclusion Criteria * Unwilling or Unable to consent to participation. * Unable to comprehend study language (Kinyarwanda or English) * Individuals who are not yet adults (infants, children, teenagers) * Prisoners * Pregnant women Note: Determination of ability to consent will be made by trained study staff prior to enrollment Interpersonal interviews and surveys: Caregivers of the potential patients will be identified from the potential patients. Potential patients will be identified by the clinical team from physical and electronic registries of patients. Potential participants will be screened for eligibility by the study research assistant. Inclusion Criteria * Caregiver (including spouses, children, family members or other individuals as designated by patients) of patients with pathologically confirmed breast or cervical cancer who are actively receiving treatment at BCCOE during the study period * Age 18 and over * Ability to provide informed consent * Ability to participate in interview or surveys in English or Kinyarwanda Exclusion Criteria * Unwilling or Unable to consent to participation. * Unable to comprehend study language (Kinyarwanda or English) * Individuals who are not yet adults (infants, children, teenagers) * Prisoners * Pregnant women Note: Determination of ability to consent will be made by trained study staff prior to enrollment Institutional Focus group: An official participation letter will be sent from BL2TH to leaders of the preselected facilities. Interested participants will be encouraged to contact the study team. Potential participants will be invited by their hospital/center leadership and screened for eligibility by the study research assistant. Inclusion Criteria * Healthcare Worker * Working in a preselected health center, district hospital, provincial hospital in the Northern Province * Age 18 or older * Ability to provide informed consent * Ability to participate in interview or surveys in English or Kinyarwanda Exclusion Criteria * Unwilling or Unable to consent to participation. * Unable to comprehend study language (Kinyarwanda or English) * Individuals who are not yet adults (infants, children, teenagers) * Prisoners * Pregnant women Note: Determination of ability to consent will be made by trained study staff prior to enrollment Institutional surveys: Formal participation invitation will be sent to the Rwanda Medical and Dental Council, National Council of Nurses and Midwives, and the Rwanda Allied Health Professions Council. Potential participants will be screened for eligibility electronically and informed consent obtained electronically. Inclusion Criteria * Healthcare Worker * Registered with relevant professional organization in Rwanda * Age 18 or older * Ability to provide informed consent * Ability to participate in surveys in English or Kinyarwanda Exclusion Criteria * Unwilling or Unable to consent to participation. * Unable to comprehend study language (Kinyarwanda or English) * Individuals who are not yet adults (infants, children, teenagers) * Prisoners * Pregnant women Note: Determination of ability to consent will be made by trained study staff prior to enrollment Aim 2 Inclusion and Exclusion Criteria Aim 2 Intervention pilot (patient, caregivers and community health workers) Patient and Caregiver Pilot: Inclusion Criteria * Patients with pathologically confirmed breast cancer who are actively receiving curative-intent treatment at BCCOE during the study period and a designated caregiver * Patients getting systemic neoadjuvant chemotherapy who are expected in the clinic on a 3-week cycle * Patients who have at least 4 cycles of therapy remaining * Age 18 and over * Ability to provide informed consent * Ability to participate in pilot, interview, and surveys in English or Kinyarwanda Exclusion Criteria * Unwilling or Unable to consent to participation. * Unable to comprehend study language (Kinyarwanda or English) * Individuals who are not yet adults (infants, children, teenagers) * Prisoners * Pregnant women Note: Determination of ability to consent will be made by trained study staff prior to enrollment Community Health Worker Pilot: Inclusion Criteria * Community Health Worker registered with relevant healthcare facilities in Northern Rwanda * Age 18 or older * Willing to engage in activities related to breast and cervical cancer and to support survivors * Ability to provide informed consent * Ability to participate in pilot, interview, and surveys in English or Kinyarwanda Exclusion Criteria * Unwilling or Unable to consent to participation * Unable to comprehend study language (Kinyarwanda or English) * Individuals who are not yet adults (infants, children, teenagers) * Prisoners * Pregnant women

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm cervical cancer Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Cervical cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Butaro Level 2 Teaching Hospital (BL2TH), Ministry of Health

    Butaro, Rwanda

  • University of Global Health Equity (UGHE)

    Butaro, Rwanda

More trials for these conditions

Other studies related to the condition(s) this trial covers.